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ABSTRACT
Extracerebral toxoplasmosis, with pulmonary involvement and shock, is a rare form of toxoplasmosis in patients with 
advanced AIDS. It can mimic pneumocystosis, histoplasmosis, and disseminated tuberculosis, and should be considered 
in the differential diagnosis of causes of respiratory failure and fulminant disease in this group of individuals, especially 
in areas where the Toxoplasma gondii infection is highly prevalent and in those without proper use of antimicrobial 
prophylaxis. We report the case of a 46-year-old male patient who presented to the emergency department with 
uremia, requiring urgent dialysis. During the laboratorial investigation, the patient had confirmed HIV infection, with a 
low CD4+ peripheral T-cell count (74 cells/µL). During hospitalization, the patient presented drug-induced hepatitis due 
to trimethoprim/sulfamethoxazole in a prophylactic dose, requiring interruption of this medication. On the 55th day 
of hospitalization, the patient developed refractory shock and died. At the autopsy, disseminated toxoplasmosis with 
encephalitis and severe necrotizing pneumonia were diagnosed, with numerous tachyzoites in the areas of pulmonary 
necrosis. 
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CASE REPORT
A 46-year-old male with a history of drug, alcohol 
and tobacco abuse was admitted to the emergency 
department with altered level of consciousness. 
At admission, no close companion was present 
to provide a detailed medical history. A complete 
clinical examination and various laboratory tests 
were performed, and uremia was diagnosed. 
The lab tests showed a serum creatinine level of 
17.2 mg/dL (reference range [RR] = 0.7-1.2 mg/dL); 
serum urea 318 mg/dL (RR = 10-50 mg/dL); hemoglobin 
4.8 g/dL (RR: 13-18g/dL) with intense poikilocytosis; 
peripheral white blood cell count 5,220 cells/mm3 
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(RR = 4,000-11,000 cells/mm3); total peripheral lymphocyte 
count 400 cells/mm3 (RR = 900-3,400 cells/mm3); 
arterial pH 7.208 (RR: 7.37-7.44) and serum bicarbonate 
6.1 mmol/L (RR: 23-29 mmol/L). A head computed 
tomography (CT) and a lumbar puncture were also 
carried out, both of which showed normal results. 
Dialytic treatment and adjuvant measures were 
then initiated, and the patient’s mental and general 
condition improved progressively over the next few 
days. The serology panel requested at admission 
showed two ELISA positives for HIV antibodies, 
non-immunization for HBV, a positive Toxoplasma 
immunoglobulin (Ig)G (by electrochemiluminescence, 
with 650.0 IU/mL [RR ≥ 3 IU/mL]) and a positive 
HVA IgG. Other serologic tests, including anti-hepatitis 
C virus (HCV) and anti-T. cruzi antibodies were 
negative. The HIV infection was then confirmed by 
Western blotting. However, the patient was not aware 
of his HIV status. The TCD4+ peripheral count was 
74 cells/µL, TCD8+ peripheral count was, 171 cells/ µL 
(TCD4+/TCD8+ ratio = 0.43) and the HIV-1 RNA viral 
load in the blood was 66,309 copies/mL (branched 
DNA) or 4.82 Log. The blood cultures were negative.
On the 28th day of  hospi ta l izat ion,  the 
p a t i e n t  m a n i f e s t e d  a c u t e  h e p a t i t i s ,  w i t h 
significant elevation of serum canalicular enzymes 
(direct bilirrubin (DB) = 2.63 mg/dL [RR < 0.3 mg/dL], 
alkaline phosphatase (AP) = 1,248 U/L [RR: 40-129 
U/L]) and liver enzymes (AST = 172 U/L [RR < 37 U/L], 
ALT = 447 U/L [RR < 41 U/L]) attributed to trimethoprim/
sulfamethoxazole (TMP/SMX) prescribed to prevent 
opportunistic infections. The detection of HCV RNA 
by the real-time polymerase chain reaction assay 
was negative in the blood. These antibiotics were 
discontinued for 2 weeks, when the canalicular enzyme 
levels returned to the reference range. Combined 
antiretroviral therapy (ART) was not prescribed during 
hospitalization due to the patient’s liver dysfunction. 
On the 55th day of hospitalization, the patient 
developed refractory shock attributed to nosocomial 
pneumonia as he presented cough, fever, and thoracic 
rales (see chest x-ray and chest CT in Figure 1). 
Bronchoalveolar lavage (BAL) was not performed due 
to the poor clinical condition of the patient.
Broad-spectrum antibiotics and vasoactive 
drugs were prescribed associated with dialysis and 
mechanical ventilation, but the patient did not respond 
favorably and died. The blood cultures were negative, 
and the microscopic analysis and culture of the sputum 
were negative. The autopsy was requested and 
was performed with the agreement of the patient’s 
relatives.
Figure 1. Radiological findings of pulmonary toxoplasmosis: A – supine chest x-ray showing diffuse bilateral 
pulmonary opacities and obliteration of left inferior hemithorax. Also note the tracheal tube and venous catheters; 
B – Axial computed tomography (lung window) showing bilateral centrilobular ground-glass opacities, consolidation 
of posterior portions of the lungs, and small bilateral pleural effusions.
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AUTOPSY FINDINGS
The corpse weighed 65 kg and measured 
177 cm (body mass index 20.74). The external 
examination was unremarkable. The lungs were 
heavy (the right lung weighed 1,126 g and the 
left lung 936.0 g [RR = 400-800 g]), congested, 
and showed signs of anthracosis. The parenchymal 
cut surface was violaceous, friable, with diffuse 
consolidation (lung hepatization), associated with 
abundant purulent secretions draining from the 
airways. Microscopic examination revealed significant 
congestion and pneumonia characterized by scattered 
foci of necrosis, a variable number of mononuclear 
and polymorphonuclear inflammatory cells (Figure 2) 
associated with granular eosinophilic cysts and free 
arc-shaped structures with eccentric nuclei (measuring 
7 µm) compatible with Toxoplasma gondii cysts and 
tachyzoites, respectively (Figure 3).
The cysts were periodic acid Schiff (PAS) positive 
and the immunohistochemistry (IHC) for the T. gondii 
antigen (Rabbit Polyclonal Antibody, Cell Marque™) 
was positive in both cysts and tachyzoites (Figure 4).
The liver weighed 1,570 g (RR: 1,400-1,600 g), 
was extremely congested, and had a finely granular 
capsule. The histology demonstrated cirrhosis with 
dense mononuclear inflammatory infiltrates in the 
portal tracts, focal steatosis, centrilobular congestion, 
Figure 2. Micrograph of pulmonary toxoplasmosis. A – Septal congestion, alveolar edema, foci of necrosis scattered 
in the lung parenchyma (arrows). Anthracosis is observed (H&E, 10X); B – Interstitial pneumonia and areas of intra 
alveolar exudate and lytic necrosis, T. gondii forms, not seeing at this magnification (H&E, 70X).
Figure 3. Micrograph of pulmonary toxoplasmosis. A – Areas of exudative pneumonia with free T. gondii tachyzoites 
(arrows) in the alveolar space. The inflammatory tissue reaction is weak, with few alveolar macrophages, lymphocytes, 
and neutrophils (H&E 630X); B – Rupture of a T. gondii cyst in a lung parenchymal cell (H&E 630X).
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and necrosis of hepatocytes. The spleen weighed 
268.0 g (RR; 100.0 -150.0 g), and the red pulp was 
friable. Microscopic analysis showed that the red pulp 
exhibited splenitis and hemorrhagic foci, and that 
the white pulp had an intense lymphocytic depletion. 
The kidneys were both atrophic, with a granular 
external surface. Microscopic examination revealed 
diffuse glomerular hyalinization, some glomeruli 
with collapse of the glomerular tuft (collapsing 
glomerulopathy), cystic dilatation of the renal tubules, 
chronic interstitial nephritis associated with interstitial 
fibrosis, and tubular atrophy (Figure 5).
The bone marrow was hypercellular due to increased 
granulocytic-lineage cells, and numerous plasmacytes 
and micromegakaryocytes. The brain weighed 1,302 g 
(RR: 1,200-1,600 g) and was congested and edematous. 
Microscopy showed sparse areas of necrosis associated 
with congestion, edema, and discrete interstitial and 
perivascular lymphohistiocytic infiltrate. The T. gondii 
antigen was detected by immunohistochemistry in the 
cytoplasm of inflammatory cells, confirming central 
nervous system involvement (Figure 6). The heart 
weighed 512 g (RR: 200-350 g) and had concentric 
left ventricular hypertrophy, with no signs of T. gondii 
infection at the microscopic level. The eyes were 
not examined, and other organs had no significant 
histological features. The Grocott’s, Gram, and Ziehl-
Neelsen stains were negative in the lungs, brain, heart, 
and bone marrow. Tissues were not collected for 
postmortem microbiological analysis.
DISCUSSION
The case reported herein depicts a male patient 
who was unaware of his HIV status and arrived in the 
emergency facility with uremia due to a late-stage 
Figure 4. Micrograph of pulmonary toxoplasmosis. 
The immunohistochemistry revealed numerous 
intracellular and extracellular forms of T. gondii 
(Peroxidase, Rabbit Polyclonal Antibody, Cell 
Marque™ 400X).
Figure 5. Micrograph showing some histopathological aspects of AIDS-associated nephropathy. A – Collapse of 
glomerular capillaries, dilatation of the Bowman capsule, podocytes hypertrophy, tubular cystic dilatation, and 
interstitial chronic nephritis with interstitial fibrosis (H&E, 200X); B – The Masson’s Trichrome stain shows collagen 
deposition in the glomeruli, some with thick Bowman capsule (arrows) and others with glomerular sclerosis 
(arrowheads). On the bottom, interstitial fibrosis is evident (Masson’s trichrome, 90X).
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of AIDS-associated nephropathy, requiring urgent 
dialytic treatment. The patient was also in the late 
stage of AIDS, according to the low peripheral 
TCD4+ lymphocyte count. He evolved to refractory 
shock after 50 days of hospitalization and died. 
The autopsy showed an unsuspected pre-mortem 
disseminated toxoplasmosis (class I of discrepancy by 
Goldman criteria),1 affecting the brain and the lungs. 
Death was a result of severe disseminated toxoplasmosis 
causing diffuse necrotizing pneumonia, encephalitis, 
and refractory septic shock. Morphological features of 
alcoholic liver disease in the cirrhotic stage were also 
found. The liver disease decompensated whilst the 
patient was taking prophylactic TMP/SMX, leading to 
drug discontinuation, which certainly influenced the 
reactivation and spread of T. gondii.
The Brazilian public health system is internationally 
recognized as a model for the treatment of HIV/AIDS 
infection. However, cases of late-stage diagnosed 
HIV infection (or late entry, defined as CD4+ T 
cells <350 cells/µL, the presence of AIDS-defining 
diseases, or death attributed to HIV at diagnosis) still 
represent a problem in the care of people living with 
HIV/AIDS (PLHA) in the country.2
Toxoplasmosis has a worldwide distribution 
and is caused by the intracellular protozoan parasite 
T. gondii.3 The Brazilian seroprevalence of T. gondii 
infection is considered one of the highest in the world; 
it is estimated at 36-92% among pregnant women 
and 56% among young military men.4 Most of the 
newly infected immunocompetent people tend to 
be asymptomatic and a latent T. gondii infection can 
persist for a lifetime, and can reactivate in the case 
of immune system impairment (such as AIDS). A few 
people with primary infection may have prolonged 
lymphadenopathy and, rarely, pneumonitis and 
hepatitis.3-5
AIDS patients with toxoplasmosis commonly 
experience T. gondii reactivation, with focal encephalitis, 
Figure 6. Micrograph of diffuse T. gondii encephalitis. A – Glial nodule in the hippocampus associated with 
neuropil edema (H&E 100X); B – Glial nodule in the subcortical white matter. T. gondii forms were not seeing in the 
inflammatory reaction composed of histiocytes and lymphocytes (H&E 300X); C – Perivascular inflammatory infiltrate 
with discrete hemorrhage and edema (H&E 200X); D – The T. gondii antigen was detected by IHC in the cytoplasm 
of rare inflammatory cells (Peroxidase, Rabbit Polyclonal Antibody, Cell Marque™ 200X).
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producing mass effect as the main clinical feature.6 
The extracerebral disease may also occur, with lungs 
and eyes being the most common affected sites, 
although any organ or system can eventually be involved 
when the infection is disseminated.3,5,7 Even though 
the real incidence of cerebral toxoplasmosis—as an 
AIDS-defining disease in Brazil—is not well known, 
this incidence is declining since the introduction of 
ART, corresponding to 10% of all reported cases of 
AIDS in the São Paulo State between 2001 and 2005.8 
The odds of reactivated toxoplasmosis can be up to 
30% amid PLHA with low TCD4+ peripheral count (less 
than 100 cells/µL), with positive serum anti-T. gondii 
IgG, who don’t receive proper prophylaxis or ART.9 
Discontinuation of TMP/SMX increases the risk of 
T. gondii encephalitis10 as we observed in the clinical 
course of this current case report.
Toxoplasma pneumonitis accounts for up to 
4% of all HIV-related pulmonary diseases11 and 
can be associated with respiratory insufficiency, 
metabolic acidosis, disseminated intravascular 
coagulation, refractory septic shock, encephalitis, and 
myocarditis.3,12,13 The clinical and radiological features 
of T. gondii pneumonitis can mimic Pneumocystis 
jirovecii pneumonia.5,14,15 The most common symptoms 
are cough associated with pulmonary rales, fever, 
dyspnea, and respiratory failure. Rabaud et al.5 
described 64 cases of AIDS-associated pulmonary 
toxoplasmosis in France, with isolated lung disease 
in 61%, lung disease associated with cerebral 
toxoplasmosis in 25%, ocular lesion in 8%, fatal septic 
shock in 15.6%, chest roentgenographic abnormalities 
in 51.5%, clinical response to treatment in 47%, 
recurrence in 23%, and death due to toxoplasmosis 
in 37% of cases. Although the diagnosis of cerebral 
toxoplasmosis is preemptive in most cases, the 
diagnosis of pulmonary toxoplasmosis should be 
confirmed by methods that demonstrate the presence 
of T. gondii in the pulmonary parenchyma, since the 
differential diagnosis of the most common causes of 
pulmonary disease in PLHA (such as pneumocystosis, 
mycobacteriosis, and cryptococcosis) must be ruled 
out.5,13-16 The diagnosis of pulmonary toxoplasmosis 
can be made by (i) visualizing tachyzoites through the 
microscopic examination of bronchoalveolar lavage 
(stained by Giemsa, indirect immunofluorescence 
or IHC); (ii) cell or laboratory animal inoculation 
of BAL, tissues or other fluids; (iii) detecting the 
T. gondii-B1 gene; and (iv) histopathologic exam 
of tissue samples.5,15-17 Most cases of pulmonary 
toxoplasmosis have high serum titers of anti-T. gondii 
IgG, but serology is not a well-validated method for 
the diagnosis of extracerebral toxoplasmosis.5 High 
serum levels of lactic dehydrogenase can be detected 
in pulmonary toxoplasmosis.14
The chest x-ray in pulmonary toxoplasmosis may 
be normal or exhibit bilateral and diffuse interstitial 
infiltrates (most common finding), bilateral interstitial 
infiltrates with nodular densities, solitary nodular 
lesions, nodular densities with pleural effusion, 
isolated pleural effusion, bilateral white lung, and 
pneumothorax.5,15,18,19 The tomographic findings in 
the pulmonary toxoplasmosis include bilateral septal 
and peribronchovascular thickening, ground-glass 
opacities, atelectasis, random nodules, lymph node 
enlargement, and pleural effusion.20
The histopathology of pulmonary toxoplasmosis 
is described in a few case reports and autopsy 
studies.3,19,21,22 The lungs are usually heavy, often 
having a combined weight of more than 2,000 g. 
The cut surface may exhibit congestion, consolidation, 
cavitation, petechial hemorrhages, disseminated 
miliary necrotic nodules (measuring 2-6 mm in 
diameter) or foci of necrotizing bronchopneumonia. 
The microscopic patterns of pulmonary toxoplasmosis 
include interstitial pneumonitis, diffuse alveolar 
damage, and focal or diffuse necrotizing pneumonia. 
The inflammatory reaction may be minimal or discrete 
lymphohistiocytic. Neutrophils and eosinophils are 
variable, and hyperplasia of type II pneumocytes can be 
seen. The parasite is found in the areas of coagulative 
necrosis as free tachyzoites or as cysts of bradyzoites. 
The tachyzoites are the rapidly dividing infective form 
of T. gondii, measuring less than 10 µm and can be 
mistaken for necrotic debris using the hematoxylin-eosin 
(H&E) stain. The Giemsa stain highlights the tachyzoites 
in the tissues. The bradyzoites can form cysts inside 
the cytoplasm of histiocytes and alveolar macrophages, 
the endothelial cells, alveolar lining cells, and smooth 
muscle cells lining the airways and blood vessels.
Cysts containing bradyzoites can be seen by H&E 
and are highlighted by the PAS stain.3,16,19,21,22 Some 
authors propose the histopathology of pulmonary 
toxoplasmosis has evolutionary morphological 
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aspects: the early stage being interstitial pneumonitis 
with diffuse alveolar damage and few parasites in 
the cytoplasm of cells. With the progression of the 
disease, cellular lysis, tissue necrosis, and the release of 
tachyzoites into the extracellular medium occur.16,22 It is 
important to emphasize that, in autopsies of patients 
with advanced AIDS, multiple opportunistic infections 
and other pathologies can be detected during the 
histopathological examination.19,22
Another important finding in the present autopsy 
was HIV-associated nephropathy. The patient had no 
previous history of systemic arterial hypertension, and an 
earlier echocardiogram showed normal left ventricular 
function, with slight hypertrophy of the posterior wall 
of the left ventricle and septum (both 1.2 cm thick). 
HIV-associated nephropathy (HIVAN) is a rapidly 
progressive disease (from weeks to a few months), 
conferring high morbidity.23 The prevalence of HIVAN 
is variable, being more common in Afro-descendants, 
depending on the geographical area (more common 
in Africa). Also, it is more common in individuals with 
low CD4+ T cell count and high viral load, which was 
the case with our patient. In Brazil, the prevalence of 
HIVAN is estimated to be 5.6%.24
CONCLUSION
The present autopsy shows the importance of 
the postmortem exam in patients with advanced 
AIDS (as well as with other immunocompromising 
conditions), revealing pathologies not clinically 
diagnosed. Two major diagnoses were made in 
this autopsy: (i) disseminated toxoplasmosis with 
pulmonary and cerebral disease; and (ii) HIV-associated 
nephropathy. Pulmonary toxoplasmosis must be 
considered in the differential diagnosis of interstitial 
pneumonia and respiratory failure in PLHA who are 
not taking prophylactic and antiretroviral treatment.
The unfortunate outcome of the case reported 
herein highlights the importance of general preventive 
measures in the care of PLHA: regular testing and early 
diagnosis of HIV infection; regular medical follow-up; 
screening for previous infectious and common diseases 
including toxoplasmosis, hypertension, metabolic and 
renal disease; the introduction of ART; and prophylaxis 
against opportunistic diseases, as well as their early 
diagnosis and treatment.25,26
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